ICI IS LAUNCHING GENERIC ATENOLOL AT A 16.7% DISCOUNT FROM TENORMIN BRAND LIST PRICE; IPR SEPARATE VERSION ANTICIPATES SEPTEMBER 17 PATENT EXPIRATION